Publikationen, an denen er mitarbeitet Alicia Rodríguez Gascón (53)

2023

  1. Terapia génica

    Fundamentos de farmacología básica y clínica (Editorial Médica Panamericana), pp. 137-153

2007

  1. Proceedings del VIII Congreso de la Sociedad Española de Farmacia Industrial yGalénica

    Leioa : Universidad del País Vasco. Servicio Editorial = Euskal Herriko Unibertsitatea. Argitalpen Zerbitzua, 2007

2003

  1. Release of salbutamol enantiomers from HPMC matrices elaborated by wet granulation

    VI Congreso de la Sociedad Española de Farmacia Industrial y Galénica. 3ª Jornadas de Tecnología Farmecéutica. Granada, 9-11 de febrero de 2003.: Libro de Comunicaciones (Comares), pp. 447-450

  2. Release of salbutamol enantiomers from HPMC matrices elaborated by wetgranulation

    Congreso de la SEFIG (4º. Granada. 2003). 3as. Jornadas de Tecnología Farmacéutica

2002

  1. In vitro and in vivo equivalence of two oral atenolol tablet formulations

    Arzneimittel-Forschung/Drug Research, Vol. 52, Núm. 5, pp. 371-378

  2. Pharmacokinetics and tissue distribution of intravenous pefloxacin for antibiotic prophylaxis in biliary surgery

    Biopharmaceutics and Drug Disposition, Vol. 23, Núm. 7, pp. 293-300

  3. Preparation and stability of agarose microcapsules containing BCG

    Journal of Microencapsulation, Vol. 19, Núm. 2, pp. 237-244

  4. Release of ketoprofen enantiomers from HPMC K100M matrices - Diffusion studies

    International Journal of Pharmaceutics, Vol. 239, Núm. 1-2, pp. 61-68

  5. Release of salbutamol sulphate and ketoprofen enantiomers from matrices containing HPMC and cellulose derivatives

    Chirality, Vol. 14, Núm. 10, pp. 806-813

  6. Stereoselective release of ketoprofen from matrices containing cellulose derivatives

    World Meeting ADRITELF/APGI/APV (4th. Florencia. 2002)

2001

  1. Stereoselective release of ketoprofen from matrices containing cellulose derivatives

    Congreso de la Sociedad Española de Farmacia Industrial y Galénica (SEFIG) (5º. Valencia. 2001)

  2. “In vitro” and “in vivo” equivalence of two oral atenolol formulations

    Congreso de la Sociedad Española de Farmacia Industrial y Galénica (SEFIG) (4º. Valencia. 2001)

2000

  1. Effect of aging on the release of salbutamol sulfate from lipid matrices

    Spanish-Portuguese Conference on Controlled Drug Delivery (4º. Vitoria-Gasteiz. 2000)

  2. Effect of lecithins on BCG-alginate-PLL microcapsule particle size and stability upon storage

    Journal of Microencapsulation, Vol. 17, Núm. 3, pp. 363-372

  3. La unidad de desarrollo farmacéutico

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 4, pp. 69-73

  4. Pharmacokinetics of ofloxacin enantiomers after intravenous administration for antibiotic prophylaxis in biliary surgery

    Journal of Clinical Pharmacology, Vol. 40, Núm. 8, pp. 869-874

  5. Release of ketoprofen enantiomers from sodium alginate matrices

    Spanish-Portuguese Conference on Controlled Drug Delivery (4º. Vitoria-Gasteiz. 2000)

  6. Release of salbutamol enantiomers from Carbopol 940® matrices

    Spanish-Portuguese Conference on Controlled Drug Delivery (4º. Vitoria-Gasteiz. 2000)

  7. Salbutamol stereoselective diffusion from hydroxypropyl-methyl cellulose K100 Mgels

    Spanish-Portuguese Conference on Controlled Drug Delivery (4º. Vitoria-Gasteiz. 2000)